Based on research at Ludwig Maximilian University of Munich and Max-Planck-Institute for Biophysical Chemistry, Modag has launched out of stealth with $14m in series A funding.

Cancer Research UK has partnered SV Health Investors to launch a $250m commercialisation fund, building on their successful collaborations before in establishing Artios and Kudos.

Immuno-oncology therapy developer Century Therapeutics has emerged from stealth, having been established by Versant Ventures to advance Stanford and Harvard research.

The nano medicine technology developer received $11.2m in a Mandatum Life and Ilmarinen-backed round.

Immuno-oncology therapy developer Century Therapeutics has emerged from stealth, having raised $250m from Leaps by Bayer, which invested $215m, and Fujifilm subsidiary FCDI.

The Tencent-backed online medicine distributor has reportedly increased its valuation to more than $1bn in a series C3 round of undisclosed size.

Health management app developer Livongo Health was valued at $800m as of 2018, and a range of corporate investors could exit in the offering.

Online pharmacist 1mg has completed a series D round that reportedly valued the Intel-backed company at $200m.

Ahren Innovation Capital, co-founded by eight Cambridge, UK, researchers, has reached its final close, having attracted limited partners including Unilever, Sky and Aviva.

UPMC and Kaiser Permanente are both in line for exits after health data platform developer Health Catalyst filed for a $100m initial public offering.